Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Aiforia: Speculative play if you have an appetite for risk

Research 04.11.2026, 09.08 by Antti Siltanen, Antti Luiro
Aiforia Technologies

Biohit: Market in a gloomy mood

Research 04.11.2026, 09.43 by Antti Siltanen
Biohit

Modulight: Nascent growth at a reasonable price

Research 03.11.2026, 09.38 by Antti Siltanen
Modulight

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Nightingale: Contracts keep flowing

Research 03.11.2026, 09.04 by Antti Siltanen, Antti Luiro
Nightingale Health

Orion Q3'26: Endnu et stærkt regnskabskvartal

Research 29.10.2026, 07.00 by Antti Siltanen
Orion

Nightingale’s deal flow keeps a healthy beat

Analyst Comment 29.10.2026, 08.05 by Antti Siltanen
Nightingale Health

Aiforia update: Foothold in the US market strengthens through the PathAI partnership

Video 26.10.2026, 14.45 by Antti Siltanen
Aiforia Technologies

Nexstim Q3'26: System deliveries point to a growth year

Analyst Comment 26.10.2026, 10.40 by Antti Siltanen
Nexstim

Modulight Q3'26: Surprise quarter, at least on earnings

Research 26.10.2026, 08.11 by Antti Siltanen
Modulight

Orion: Positive foreløbige resultater for Nubeqas effekt i ny indikation

Analyst Comment 26.10.2026, 06.45 by Antti Siltanen
Orion